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This study was intended to, meta-analytically, review whether the subtests of the Wech-
sler Adult Intelligence Scale are useful in differentiating between vascular dementia
and Alzheimer’s disease. We expected the Alzheimer’s disease group to outperform the
vascular dementia group on those subtests that require executive functions, whereas
inferior performance of the Alzheimer’s disease patients was expected on memory
tests. Two steps in the analysis were undertaken in an attempt to clarify this issue. The
first step consisted of including all studies examining Wechsler Adult Intelligence
Scale subtest performance in vascular dementia and Alzheimer’s disease patients.
Secondly, a subcortical vascular dementia subgroup was distinguished and performance
of this subgroup was compared to that of the Alzheimer’s disease group.
Overall, the analyses showed that both the vascular dementia and, more strongly,
the subcortical vascular dementia group revealed decreased executive functions on
several subtests compared to the Alzheimer’s disease group. The Alzheimer’s disease
group showed inferior performance on a single semantic memory test only compared
to both the vascular dementia and the subcortical vascular dementia groups. These
results indicate that several subtests of the Wechsler Adult Intelligence Scale can
differentiate between these two clinical groups, and that most of these tests reveal
more impaired performance in the vascular dementia group.
Introduction
Two of the most common observed variants of dementia are Alzheimer’s disease (AD) and
vascular dementia (VaD) (Desmond, 1996). Both subtypes of dementia present profiles
with distinguishable cognitive deficits, like executive dysfunctioning in VaD compared to
a pronounced memory deficit in AD (Freeman et al., 2000; Graham, Emery & Hodges,
2004; Looi & Sachdev, 1999; Traykov et al., 2002). Traykov and co-workers (2002) found
that AD patients had inferior performance on free and delayed recall and recognition as
opposed to VaD patients, while the VaD group made more perseverative errors on the
modified card sorting test, a test of executive functioning (EF). In accordance, Freeman et al.
(2000) observed a decrement in delayed recognition memory performance of a modification
of the Rey-Osterrieth Complex Figure in AD patients compared to the VaD group,
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whereas the VaD group showed inferior performance on the copy condition, a condition
strongly dependent upon working memory. However, differentiating these two clinical
pictures based on neuropsychological tests remains indefinite (Almkvist, Fratiglioni,
Aguero-Torres, Viitanen & Backman, 1999; Fahlander, Wahlin, Almkvist & Backman,
2002). Several reasons for this variability have been presented, including the heterogene-
ity in the diagnosis of VaD (Graham et al., 2004). Also, vascular risk factors, such as
hypertension, that are known to cause brain damage and thereby cognitive impairment
(Carmelli et al., 1999; Raz, Rodrigue & Acker, 2003) are present in both VaD and, to a
lesser degree, in AD (Rockwood et al., 2000). Probably, the presence of these risk factors
in both dementia subtypes contributes to an overlap in neuropathology and, hence, compa-
rable cognitive deficits. In general, both subtypes of dementia are characterized by a dif-
ferent neuropathology. Micro-infarction, diffuse white matter disease and perivascular
changes are the most prominent features of VaD, while amyloid plaques and neurofibrillary
tangles normally typify AD (Kalaria, 2002). Accumulating evidence, however, indicates
co-occurrence of these pathologies in VaD and AD (Kalaria, 2002; Kalaria & Ballard,
1999). For example, abnormalities in the white matter are present in both VaD (Giovan-
netti et al., 2001) and AD (Bigler et al., 2003; Tsiskaridze, Shakarishvili, Janelidze,
Vashadze & Chikhladze, 1998). In line with these observations is that a cholinergic dys-
function, characteristic for AD, is also observed in VaD (Lojkowska et al., 2003). Further-
more, a ‘mixed dementia’ subtype, consisting of AD concurrent with cerebrovascular
disease, is recognised (Rockwood et al., 2000). This might diminish the differentiation
between VaD and AD based on cognitive task performance.
A neuropsychological profile occasionally applied to differentiate AD from other
forms of dementia is the ‘Fuld profile’ (Fuld, 1984). This profile is based on the Wechsler
Adult Intelligence Scale (WAIS) (Wechsler, 1955) and is composed of scores on the
following subtests: Block Design, Digit Span, Digit Symbol Substitution, Information,
Object Assembly, Similarities, and Vocabulary. Based on these subtests, a certain formula
is composed which is indicative for the presence of AD. This formula is:
A > B > C ≤ D, A > D,
in which A represents the average performance on the Information and Vocabulary subscale, B the
average performance on the Similarities and Digit Span tests, C the average performance on the
Digit Symbol Substitution and Block Design task, and D the performance on Object Assembly.
Originally described as a diagnostic marker of AD (Fuld, 1984), many studies failed
to replicate this finding (Alexander, Prohovnik, Stern & Mayeaux, 1994; Gfeller &
Rankin, 1991; Randolph, Mohr & Chase, 1993; Yamashita et al., 1997). Even though
specificity is quite high (i.e., 88.5% demented patients of the non-Alzheimer type and 93.3%
controls present with ‘negative’ Fuld profiles), sensitivity (i.e. successful identification of
AD patients) is quite low (24.1%; Massman & Bigler, 1993). Perhaps not applicable as a
composite score or profile and despite several studies revealing no differences between
both clinical groups (Loewenstein et al., 1991; Loring, Meador, Mahurin & Largen, 1986;
Padovani et al., 1995; Starkstein et al., 1996), we hypothesize that several subtests of the
WAIS could still serve to distinguish between AD and VaD. According to the idea of
more prominent executive dysfunctioning in VaD compared to AD, several subtests might
be more impaired in the VaD group than in the AD group, while performance on tests
that require memory processes will be most affected in the AD group. Furthermore, by
examining a subgroup of VaD patients, i.e. subcortical VaD (sVaD), we attempted to
reduce the variability that exists in the diagnosis of VaD. Due to this increased homogeneity
in study population as well as the strong involvement of the subcortical brain regions in
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EF (Pohjasvaara, Mäntylä, Ylikoski, Kaste & Erkinjuntti, 2003), we hypothesize that the
WAIS subtests will differentiate more profoundly between sVaD and AD.
Method
The topic of this review is to meta-analytically examine whether the subtests of the WAIS
are useful to distinguish between VaD and AD groups. Despite the evidence of the strong
resemblance in both neuropathology and pathophysiology between these two types of
dementia, it is argued that VaD will be characterized by a more dysexecutive syndrome
(Starkstein et al., 1996) while AD is accompanied by increased memory deficits (Rascovsky
et al., 2002). We are fully aware that through the multi-factorial nature of the Wechsler sub-
tests they require multiple cognitive functions and, hence, various brain areas for intact per-
formance. Also, as mentioned previously, an overlap between both pathologies does exist,
and both observations might diminish the possibility of distinguishing between VaD and AD
based on cognitive performance. Nonetheless, a cerebral blood flow study showed that cere-
bral hypoperfusion is primarily present in the parietotemporal cortex in AD and more in the
frontal areas in VaD (Nagata et al., 2000). There is ample evidence that the temporal lobe is
strongly involved in memory processes whereas the frontal cortex plays a major role in EF
(Chantal, Labelle, Bouchard, Braun & Boulanger, 2002; Culhane-Shelburne, Chapieski,
Hiscock & Glaze 2002; Stuss, Floden, Alexander, Levine & Katz 2001). Therefore, we
assume that executive dysfunctioning will characterize VaD patients whereas memory defi-
cits will be most prominent in the AD group.
All subtests of the WAIS were examined separately. Whether a task requires primarily EF
or mainly memory processes was based on existing literature. This literature consists of studies
reporting factor analyses and correlations that reveal several WAIS subtests to be strongly
related to tests of EF (e.g., Trail Making Test part B), and studies examining frontal versus either
non-frontal or temporal lesions (or activity in these brain regions), as well as the effect of sub-
cortical neuropathology (e.g., Parkinson’s disease, Huntington’s disease) on task performance.
In general, Digit Symbol Substitution and Digit Span are considered measures of EF
(Royall et al., 2002). In addition, executive processes might be involved in reduced pro-
ductivity in performing the Block Design, Picture Arrangement and Picture Completion
tests (Lezak, 1995). Indeed, based on the literature, we expected more impairment in both
the VaD and sVaD group for the following of these tests: Block Design (Johnson, Head,
Kim, Starr & Cotman, 1999; Skranes et al., 1997; Wallesch, Curio, Galazsky, Jost &
Synowitz, 2001), Digit Symbol Substitution (Boone, Pontón, Gorsuch, González &
Miller, 1998; Mahurin, Velligan & Miller, 1998; Peavy et al., 2001), Picture Arrangement
(Deckel, 1999; Hasselbalch et al., 1992; Peavy et al., 2001), and Picture Completion
(Mahieux et al., 1998; Skranes et al., 1997). Also, the Object Assembly test does reveal
frontal processing (Peavy et al., 2001; Randolph et al., 1993) and might involve an
executive component. These tests, but not the other WAIS subtests, were also found to
have the strongest loading on the same single factor (Ardila, Galeano & Rosselli, 1998)
and do represent the Performance subscale of the WAIS, which supports that these tests
measure overlapping cognitive abilities. With regard to the Digit Span test, studies do
favour a key element of executive/frontal processes in the backward and much less or not
in the forward version of this test (Hoshi et al., 2000; Leskelä et al., 1999). Therefore we
expect more impairment in the VaD group on the backward version only. In contrast, the
Information, Vocabulary, Comprehension and Similarities subtests have been described as
tests of semantic memory (Kazui, Hashimoto, Hirono & Mori, 2003), and would be more
impaired in the AD group. It is only for two out of these four tests that we expect a
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stronger involvement of memory compared to EF processing, namely the Information and
Vocabulary subtests (Dobbins & Russell, 1990). Results are unclear with regard to the
Comprehension subtest (Butters, Goldstein, Allen & Shemansky, 1998; Peavy et al., 2001;
Randolph et al., 1993). Since the Similarities subtest requires both memory functions and
executive processing (Dobbins & Russell, 1990; Insingrini & Vazou, 1997; Slachevsky
et al., 2004), it is not likely that the VaD and AD patients can be distinguished on this task.
Also, the Arithmetic test might be more impaired in AD patients (Hirono et al., 1998), but
arithmetic functions equally require frontal related processes (Dehaene, Molko, Cohen &
Wilson, 2004; Rivera, Menon, White, Glaser & Reiss, 2002), such as working memory.
This subtest together with the Similarities, Comprehension, and Digit Span forward tests
probably do not differentiate between VaD and AD (Table 1).
An extensive search was performed in Pubmed and Web of Science using search
terms such as ‘Alzheimer’s disease’, ‘vascular dementia’ or ‘multi-infarct dementia’,
‘WAIS’, ‘Wechsler’ and all subtests of the WAIS. As many studies as possible were
obtained examining performance and reporting the results separately of both demented
groups on subtests of the WAIS. Several inclusion criteria were employed. To reduce the
possible influence of the previously described heterogeneity in the diagnosis of both VaD
and AD, only studies that administered standardized diagnostic criteria including imaging
techniques such as Magnetic Resonance Imaging (MRI) were selected. These techniques
increase the probability of accurate diagnoses and, presumably, reduce the possibility of
including dementia patients with severe co-occurrence of both pathologies. Also, since
both age and severity of dementia are strong predictors of cognitive performance, only
those studies that examined a VaD and AD group that were comparable on these factors
were included. Severity of dementia was frequently assessed with instruments such as the
Mini-Mental State Examination (Folstein, Folstein & McHugh, 1975) and the Clinical
Dementia Rating scale (CDR) (Berg, 1988). It is argued that the MMSE might be more
sensitive to AD than VaD, due to its strong episodic memory load (Graham et al., 2004)
and, hence, may not reflect the true level of impairment. However, since only a few stud-
ies extended the assessment of disease severity to several diagnostic instruments, no
exclusion or inclusion criteria based on diagnostic tool could be accomplished. In case
data concerning age and severity of dementia was available but no information on the
compatibility of the groups on these measures was given, a t-test was performed to test for
possible differences. The test used to indicate the global level of cognitive impairment had
to be a deviant instrument from the Wechsler subtests we examined. For example, full
WAIS IQ score was not viewed as an appropriate indicator of level of cognitive impair-
ment, and neither were tests that examine only a single aspect of cognitive functioning
(e.g., EF as assessed with the Trail Making Test). Inappropriate matching was also consid-
ered present in case no data about age or level of cognitive impairment in the clinical
groups was provided. Finally, studies had to report data usable in this meta-analysis
(means +/− SD). We additionally enrolled studies that compared performance of these two
clinical populations on tasks from different batteries that are also part or resemble those of
the WAIS, such as the Digit Span from the Wechsler Memory Scale (WMS) (Wechsler,
1945) or the Symbol Digit Modality Test (SDMT), a revision of the Digit Symbol
Substitution test (DSS). The SDMT and DSS reveal high correlations (Bowler et al., 1990;
Morgan & Wheelock, 1992) although the raw score of the SDMT tends to be lower than
the one obtained on the DSS (Morgan & Wheelock, 1992). We do not expect this to affect
our results because only relative scores (d-size) were entered into the meta-analysis. Since
the subtests examined have sources of various origins, from now on they will be referred
to as ‘Wechsler subtests’.
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Meta-analysis
The meta-analysis was conducted using Comprehensive Meta-analysis, a statistical
program developed by Borenstein and Rothstein (1999). Cohen’s d, representing the effect
size, was calculated for each study separately, which is done with the following formula:
Cohen’s d = M1 − M2 / √[(σ12 + σ22)/2].
An overall d-value was computed with each effect size weighted for sample size of
the study. Accordingly, effect sizes of .20, .50, and .80 were used as guidelines to define
small, medium, and large effects, respectively (Cohen, 1988). When running a meta-
analysis, two different types of effects—fixed and random—must be considered. Fixed
effects are those in which studies are assumed to be comparable, that is, they are not
heterogeneous. Random effects are adjusted to correct for heterogeneity and can be
deduced from calculating the so-called Q-statistics (Hedges & Olkin, 1985). Since it is
unlikely that the studies reviewed here included strictly comparable study samples, only
random effects are reported.
The extensive literature search resulted in 33 studies examining Wechsler subtest
performance in both AD and VaD groups. Inappropriate age and severity of dementia
matching was present in 14 studies, which were therefore excluded from the meta-analysis
(Almkvist, Backman, Basun & Wahlund, 1993; Chaves et al., 1999; Crawford, Parker &
Besson, 1988; Gainotti, Parlato, Monteleone & Carlomagno, 1992; Gandolfo, Vecchia,
Moretti, Brusa & Scotto, 1985; Gfeller & Rankin, 1991; Hagberg & Gustafson, 1985;
Hier, Warach, Gorelick & Thomas, 1989; Inzelberg, Shapira & Korczyn, 1990; Mazzucchi
et al., 1987; McCleary, Dick, Buckwalter, Henderson & Shankle, 1996; Neshige, Barrett
& Shibasaki, 1988; Perez et al., 1975; Rabey, Neufeld, Treves, Sifris & Korczyn, 1996).
Due to inadequate data reports, two more studies were excluded (Carlesimo, Fadda,
Lorusso & Caltagirone, 1994; Fahlander et al., 2002). Finally, one study did not use any
imaging technique to accomplish the diagnosis, which was therefore excluded from
further analyses (Almkvist et al., 1999). Two studies did apply MRI to both groups and
additional standardized diagnostic criteria (i.e., NINCDS-ADRDA) only to the AD group
(Graham et al., 2004; Loewenstein et al., 1991), which we found sufficient for inclusion.
This resulted in 16 studies to enter the meta-analysis (Table 2), which was conducted as
follows. In the first analysis, all studies were enrolled. Secondly, to reduce the heterogeneity
within the clinical group of VaD, studies examining subcortical vascular dementia (sVaD)
Table 1
Hypothesized differences in task performance between AD and VaD patients
VaD < AD AD < VaD VaD = AD
Block Design Information Arithmetic
Digit Span backward Vocabulary Comprehension
Digit Symbol Substitution Digit Span total
Object Assembly Digit Span forward
Picture Arrangement Similarities
Picture Completion
The hypothesized neuropsychological profile to emerge when comparing the VaD and AD sub-
groups on all WAIS subtests. VaD < AD: AD patients outperform VaD patients; AD < VaD: VaD
patients outperform AD patients; VaD = AD: performance is equal in both groups.
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or VaD patients with subcortical damage as prominent pathology were selected.
Erkunjintti et al. (2000) developed useful guidelines for sVaD: “small vessel disease as the
primary vascular etiology, lacunar infarcts and ischemic white matter lesions as the
primary types of brain lesions, and subcortical location as the primary location”. The
selection for sVaD was accomplished as follows: first, studies examining multi-infarct
dementia, characterized by multiple cortical and subcortical infarctions, which represents
a subtype differing from sVaD (Romàn et al., 1993), were excluded. Even though multi-
infarct dementia could be comprised of mainly subcortical infarcts with the cortical
infarcts only representing a minority of the cases, the lack of detailed information about
the occurrence of subcortical and, equally important, cortical lesions, supported the exclu-
sion of those studies from the second part of the meta-analysis. Furthermore, we selected
those studies that revealed primarily subcortical brain damage in their VaD sample. Taken
together, seven studies were entered into this second analysis.
Results
In the presentation of the results, positive effect sizes indicate superior performance in the
AD group while negative effect sizes suggest better performance in the VaD group.
Analysis 1: AD versus VaD
In the first analysis (Table 3), studies with groups matched on age and severity of dementia
were included.
Table 3
Meta-analytic results when comparing task performance in the AD and VaD group
Wechsler Subtest
Analysis 1 Analysis 2
N total d-value P-value N total d-value P-value
Arithmetic 289 −0.13 0.73 – – –
Block Design 603 0.06 0.78 174 0.69 0.003
Comprehension 371 −0.28 0.24 – – –
Digit Span 484 −0.03 0.86 – – –
Forward 275 0.07 0.58 165 0.19 0.23
Backward 231 0.31 0.02 121 0.47 0.01
Digit Symbol substitution 719 0.05 0.61 203 0.22 0.25
Information 381 −0.38 0.006 60 −0.49 0.07
Object Assembly 424 0.465 0.03 105 0.93 0.001
Picture Arrangement 479 0.21 0.37 108 0.78 0.001
Picture Completion 312 −0.06 0.91 23 1.02 0.02
Similarities 470 0.02 0.86 60 −0.06 0.83
Vocabulary 321 0.005 0.97 – – –
The obtained effect sizes when comparing performance of the VaD group with the AD group on
all Wechsler subtests. In analysis 1 all studies were enrolled. Analysis 2 compared performance of
the sVaD with the AD group. Positive effects indicate the AD group performed superior compared
to the VaD group; negative effects suggest superior performance in the VaD group.
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EF Tests. Two EF subtests revealed significant results, namely Object Assembly (d =
0.465; p < 0.05) and Digit Span backward (d = 0.31; p < 0.05). Using Cohen’s guidelines,
these results represent small effect sizes. The results indicate that the AD group outper-
formed the VaD group on both subtests. No further significant differences between the
groups with regard to performance on EF tests were observed.
Memory Tests. The Information subscale reached statistical significance (d = −0.38; p <
0.01), although the effect size was small. Performance on the Information subscale was
significantly better in the VaD group than in the AD group. No difference in Vocabulary
task performance between the groups was observed.
Tests That Do Not Differentiate between AD and VaD. The tests for which there was no
theoretical basis to expect inferior performance in either the AD or VaD group, such as the
Similarities subtest, indeed did not reveal any group differences.
Analysis 2: AD versus sVaD
The second analysis (Table 3) included studies of sVaD patients. Four subtests (Arithmetic,
Comprehension, Digit Span total, Vocabulary) have not been studied in the sVaD group
and, hence, were not included in this part of the analysis.
EF Tests. Significant results were observed on the subtests Block Design (d = 0.69; p < 0.01),
Digit Span backward (d = 0.47; p < 0.05), Object Assembly (d = 0.93; p < 0.01), Picture
Arrangement (d = 0.78; p < 0.01), and Picture Completion (d = 1.02; p < 0.05). These
effect sizes range from small (Digit Span backward) to medium (Block Design, Picture
Arrangement) and large (Object Assembly, Picture Completion). All tests favoured AD
patients as superior performers. The Digit Symbol Substitution test was the only EF test
on which the AD and VaD group did not perform differently.
Memory Tests. The Information subtest, the only memory test examined here, was per-
formed better in the VaD group and revealed a small effect size that was marginally sig-
nificant (d = −0.49; p = 0.07).
Tests That Do Not Differentiate between AD and VaD. Again, the tests that were not
expected to show any group difference indeed revealed no significant results.
Discussion
The present meta-analysis showed that the (s)VaD group performed worse on various sub-
tests compared to the AD group. Conforming to the expectation, executive dysfunctioning
seems more pronounced in sVaD compared to AD as indicated by several EF subtests
(e.g., Digit Span backward, Object Assembly, Picture Arrangement). Memory dysfunction
characteristic for AD compared to VaD patients was only indicated by decreased
performance on the Information subtest, a test of semantic memory. The other semantic
memory test, Vocabulary, was not examined in the sVaD group, which prevented compar-
ing performance of the AD and sVaD group on this measure in this meta-analysis. The
finding that most tests were not specifically affected in the AD group as compared to the
(s)VaD patients, probably explains why the Fuld profile lacks sensitivity in diagnosing
AD: the subtests do not measure those abilities in which AD patients normally show
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decreased performance (Graham et al., 2004). Indeed, performance on memory tasks is
hardly assessed by the Wechsler subtests that make up the WAIS. Especially episodic
memory functions, as assessed with, for example, story recall, reveal more impairment in
AD compared to VaD (Graham et al., 2004; Kertesz & Clydesdale, 1994; Padovani et al.,
1995; Villardita, 1993), are not encountered with these Wechsler subtests.
Although executive dysfunctioning has frequently been shown to be characteristic for
VaD (e.g., Desmond, 2004), this review indicates that, in contrast to previous reports, the
Wechsler subtests do reveal a difference in performance between VaD and AD.
The multi-factorial nature of the Wechsler subtests implies that they address various
cognitive functions and, as a result, impairment in each single cognitive function could
already result in decreased performance. Tests such as the Block Design and Object
Assembly test are often referred to as measuring constructional abilities (Lezak, 1995;
Looi & Sachdev, 1999). However, EF such as strategy (Johanson, Gustafson & Risberg,
1986) or working memory (Freeman et al., 2000) can play an important role in construc-
tional functions. Furthermore, a speed of processing component is present in several tasks
as well, which might partly depend on EF (Desmond, 2004; Grigsby, Kaye & Robbins,
1995). It can be argued that a decrement in effective initiation and monitoring of behavior,
both components of EF, could result in reduced speed of information processing. These
are only a few examples of how EF might be involved in these tasks, and more thorough
research about the precise involvement of various EF is warranted.
The studies included all employed a detailed diagnostic examination of both VaD and
AD patients, including an MRI or CT-scan, through which the possibility of heterogeneity
was at least partly reduced. More specifically, various authors report only including AD
patients without characteristics indicative of vascular etiology, such as extensive white
matter abnormalities, clinical strokes or focal neurological signs (e.g. Giovannetti et al.,
2001; Graham et al., 2004; Tei et al., 1997; Yuspeh, Vanderploeg, Crowell & Mullan,
2002). We do realize that, instead of ‘pure cases’ of VaD and AD, ‘mixed dementia’
profiles are frequently observed and that these results, as a consequence, are not always
directly applicable in dementia cases encountered by the clinician. However, we believe
that this meta-analysis might contribute to a differentiation between VaD and AD by
means of Wechsler subtests, with the Object Assembly, Information and Digit Span
backward subtests appearing most sensitive.
One of the most important questions concerns the extent to which these results can be
generalized. The studies included examined subjects ranging between 64.2 (+/−7.4) and
82.84 (+/−6.28) years of age, which covers quite a large segment of the demented elderly.
The MMSE scores from the demented elderly ranged between 16.1 (+/−4.02) and 25.3 (+/
−3.8), which represents the mild and moderate dementia stages, with little attention dedi-
cated to the severely demented group. Equally, the other instruments that were applied
revealed mild and moderate dementia in the majority of the cases (e.g., stages 5 and 6
from the Global Deterioration Scale in the study of Erker, Searight & Peterson, 1995).
Therefore, these results are probably best applicable in the mild and moderate demented
patients, but not the severely demented. One advantage is that most subjects undergoing
neuropsychological assessments will be the mild or moderate demented elderly. Espe-
cially for the mild demented patients, who often present with vague complaints and less
clear-cut evidence on imaging (e.g., MRI), the application of the Wechsler subtests might
come in use for diagnosis. As for the severely demented group, it could be argued that
these patients are way beyond being able to finish any neuropsychological tests at all and,
hence, would never be administered any sort of extensive cognitive examination, such as
all or several WAIS subtests. With standard neuropsychological tests, all severe demented
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patients perform very poorly or are unable to complete any test, often regardless of how
severe the dementia is (e.g., the MMSE-score can range from 0 to 16). In order to assess
cognitive performance in severely demented patients a suitable instrument might be the
Severe Impairment Battery (Panisset, Roudier, Saxton & Boller, 1994). With this battery,
different levels of cognitive impairment that are present within a group of severe
demented patients can be revealed. Therefore, the Severe Impairment Battery might be an
appropriate measure of cognitive functions in this group.
The utility of the WAIS as a diagnostic tool for intellectual functioning in AD patients
has been previously investigated using factor analyses. One recent study that examined the
factor structure of the WAIS-R in AD patients (Davis, Massman & Doody, 2003) revealed
three factors: Verbal Comprehension (Comprehension, Information, Similarities, Vocabu-
lary), Perceptual Organization (Block Design, Digit Symbol Substitution, Object Assem-
bly, Picture Arrangement, Picture Completion) and Freedom from Distractibility
(Arithmetic, Digit Span). This structure is similar to that observed in healthy older adults
(Burton, Ryan, Paolo & Mittenberg, 1994), which implies that the WAIS, despite not
being a useful indicator of AD, is applicable in various clinical populations as an assess-
ment of general intelligence. Although, to our knowledge, no factor analysis has been
performed in VaD patients thus far, this battery might be a useful indicator of intellectual
functioning in this group as well.
One point that warrants caution is that, despite several significant results in this meta-
analysis, the majority of studies failed to successfully distinguish between VaD and AD
based on the Wechsler subtest performance (e.g. Padovani et al., 1995; Villardita, 1993;
Yamashita et al., 1997). This might indicate that the observed group differences are small.
For example, we did find a significant effect size examining the only study that adminis-
tered the Picture Completion subtest in sVaD patients (d = 1.02, p < 0.05), which was in
contrast to the conclusion made by the authors themselves (Matsuda, Saito & Sugishita,
1998). One reason for this discrepancy might by the small sample size examined in this
study (n = 11 and n = 12 for AD and VaD patients respectively). When calculating the
overall d-value the sample size is taken into account and may strongly influence the
strength of the observed effect-sizes. However, a d-value based on a single study, as was
the case for the Picture Completion subtest, is independent from sample size. This can be
an amenable explanation why the Picture Completion subtest reached significance in our
study.
When running a meta-analysis there is always the risk of a publication bias, which
refers to the possibility of only those studies that report positive results (i.e., group differ-
ences between AD and VaD patients) are being published while studies that reveal no
group differences remain unpublished. Since the majority of the included studies did not
report any group differences on the Wechsler subtests, we estimate the possibility of a
publication bias in our study to be minimal. However, the almost continues absence of any
differences between VaD and AD patients within the studies examined here also indicates
that only small group differences are present. Therefore, if applying the Wechsler subtests
from the WAIS, the assessment should be extended with additional EF tests as well as
tests tapping memory functions. A suggestion for memory tests would be to apply subtests
from the Wechsler Memory Scale (Wechsler, 1945).
Finally, although this meta-analysis does indicate differences in performance between
VaD and AD groups, nothing can be said about the diagnostic utility of the WAIS as an
indicator of VaD or AD solely. For clinical purposes, information is required about how
the performance on EF and memory tests relates to each other within individual patients,
that is, is the cognitive impairment in VaD patients more severe for EF than for memory?
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This meta-analysis cannot provide information to clarify this issue: group differences need
not necessarily mean that raw scores of EF and memory tests differ within a patient.
Although future research should be undertaken to examine this, indications do exist that
the differentiation between semantic memory and EF within VaD and AD patients is legit-
imate. The fluency test poses an example of this, with the category and letter fluency most
commonly administered. Both tests are occasionally referred to as measuring EF, although
letter fluency is acknowledged as the most pure form of EF whereas category fluency is
often denoted as a test of semantic memory. Interestingly, a dissociation between letter
and category fluency tests in VaD and AD patients exists, in that AD patients perform
worse on category compared to letter fluency (Carew, Lamar, Cloud, Grossman & Libon,
1997; Henry, Crawford & Phillips, 2004; Monsch et al., 1997) whereas the opposite is
found in VaD patients (Carew et al., 1997). Possibly, this dissociation might also be
present with respect to the Wechsler subtests, but for now it remains speculative.
The present findings stress the importance of reducing variability within the VaD
group. Furthermore, group differences in performance on several Wechsler subtests were
revealed. The results must be considered with caution, however, since they are based on a
small number of studies; future studies should be undertaken to verify these findings.
Furthermore, when comparing performance of the sVaD and AD group, only a single
semantic memory test was included in the analysis. This hinders making any conclusions
about the nature of the memory deficit in AD patients opposed to VaD patients as assessed
with the Wechsler subtests.
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